Assessment of Serum Asprosin Level in Male Patients With Acne Vulgaris

Not Applicable

• Conditions: Acne Vulgaris
• Interventions: Diagnostic Test: serum asprosin

• Registration Number: NCT05471388
• Lead Sponsor: Sohag University

Brief Summary

Subject of interest is to evaluate serum level of asprosin in male patients with acne vulgaris, demonstrate the relation between acne vulgaris severity and level of asprosin in these patients \& the relation between metabolic syndrome in acne vulgaris and level of asprosin.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Status Verified: 2022-07
• Study Start: 2022-07-18
• Study First Submitted: 2022-07-20
• Study First Submitted QC: 2022-07-20
• Last Update Submitted: 2022-07-20
• Study First Posted: 2022-07-22
• Last Update Posted: 2022-07-22
• Primary Completion: 2023-01-18
• Study Completion: 2023-01-18

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Male
• Target Recruitment: 72

Inclusion Criteria

• Acne vulgaris male patients (>18 years) will be included.

Read More

Exclusion Criteria

• Age <18 years.
• Females.
• Patients with other inflammatory skin disorders.
• Patients with associated systemic diseases.
• Current or previous treatment with isotretinoin in the last 3 month ,anti-inflammatory drugs, systemic antibiotics, androgen or anti androgen therapy, and steroid therapy).
• Patients known on treatment of diabetes, hypertension and dyslipidemia.
• Athletes.
• Patient refusal.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
control	serum asprosin	-
case	serum asprosin	-

Primary Outcome Measures

Name	Time	Method
Assess serum asprosin level in male patients with acne vulgaris.	6 months	Assess serum asprosin level in male patients with acne vulgaris.

Trial Locations

Locations (1)

Sohag University Hospital; 🇪🇬 Sohag, Egypt